Artal Group S.A. — 13F Holdings

2026 Q1  ·  2 Positions

2026 Q1 Portfolio Activity

In 2026 Q1, Artal Group S.A. maintained a portfolio of 2 distinct positions. They heavily accumulated shares in Lexicon Pharmaceuticals Inc, increasing the position by 13.6%.
Position History hover any row below to update
Loading…
Artal Group S.A. Luxembourg, Luxembourg Family Office AUM $1,011M
Fund Overview SEC EDGAR
PCA Score Concentration Risk
Risk ENB
To Excel To CSV
Total Positions
2
Quarter
2026 Q1
Top Holding
CAVA (76.1%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-2 of 2
Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
CAVA
Cava Group Inc
Consumer Cyclical 76.11% 78.09% #1
Prev: #1
7.0
—
no change no change
P
S
9,507,990 $769,196,391
$40.95 +94.9%
$80.90 -1.4%
2023 Q2 13F Filing 2026-03-31 2026-05-14
LXRX
Lexicon Pharmac...
Healthcare 23.89% 21.91% #2
Prev: #2
7.5
—
18,553,846 13.6%
P
S
154,734,327 $241,385,550
$3.95 -43.6%
$1.56 +42.9%
2015 Q2 13F Filing 2026-03-31 2026-05-14
Showing 1-2 of 2 holdings

Unlock Full Artal Group S.A. Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Upgrade to PRO
Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →